Log in to save to my catalogue

FCX, an arylidene derivative, induces apoptosis in androgen receptor-selective prostate cancer cells

FCX, an arylidene derivative, induces apoptosis in androgen receptor-selective prostate cancer cells

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2540720425

FCX, an arylidene derivative, induces apoptosis in androgen receptor-selective prostate cancer cells

About this item

Full title

FCX, an arylidene derivative, induces apoptosis in androgen receptor-selective prostate cancer cells

Publisher

India: Wolters Kluwer India Pvt. Ltd

Journal title

Journal of cancer research and therapeutics, 2021-04, Vol.17 (2), p.401-407

Language

English

Formats

Publication information

Publisher

India: Wolters Kluwer India Pvt. Ltd

More information

Scope and Contents

Contents

Context: Rational screening of arylidene derivatives for biological activities has resulted in many lead molecules with anticancer properties with effective therapeutic window.
Aims: In the current study, FCX, an arylidene derivative, was screened for anticolon and prostate cancer activity.
Settings and Design: Prostate and colon cancer cell...

Alternative Titles

Full title

FCX, an arylidene derivative, induces apoptosis in androgen receptor-selective prostate cancer cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2540720425

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2540720425

Other Identifiers

ISSN

0973-1482

E-ISSN

1998-4138

DOI

10.4103/jcrt.JCRT_228_17

How to access this item